Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: ARRAY BIOPHARMA INC

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ARRAY BIOPHARMA INC since year 2005 are given in the first table. The second table lists detailed insider transactions reported by ARRAY BIOPHARMA INC since 2005. The reporting company's ticker symbol is ARRY. The reporting company's CIK number is 1100412. The total value of stock buying during this period is $243,191. The total value of stock sales is $4,474,040. The total value of stock exercises is $496,027.

Figure 1. Monthly insider transaction values at ARRAY BIOPHARMA INC (ARRY) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $2,869k

    $286k

    $28k

    $2k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at ARRAY BIOPHARMA INC (ARRY) in the past 24 months. See table 2 for insider transaction details.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $14.06

    $10.54

    $7.03

    $3.51



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for ARRAY BIOPHARMA INC (ARRY).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-04 0 0 0 0 71,249 42,749
2008-03 37,500 233,368 0 0 0 0
2008-02 0 0 0 0 57,284 21,551
2008-01 0 0 0 0 20,694 4,863
2007-12 0 0 0 0 10,000 6,000
2007-11 0 0 0 0 10,000 6,000
2007-09 0 0 10,000 130,000 0 0
2007-08 0 0 12,000 137,662 14,000 116,480
2007-02 0 0 20,000 281,100 20,000 4,700
2007-01 0 0 26,900 376,600 0 0
2006-12 0 0 0 0 8,500 1,997
2006-11 0 0 253,133 2,869,786 249,858 291,687
2006-10 0 0 5,000 49,750 0 0
2006-03 0 0 5,000 47,450 0 0
2006-02 0 0 54,365 489,442 0 0
2005-06 0 0 15,000 92,250 0 0
2005-03 1,315 9,823 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for ARRAY BIOPHARMA INC (ARRY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-04-16 Conway Robert (CEO) Option Exercise 51,249 .60 30,749
2008-04-09 Conway Robert (CEO) Option Exercise 20,000 .60 12,000
2008-03-10 Lefkoff Kyle (Director) Purchase 5,000 5.38 26,925
2008-03-06 Williams Douglas E (Director) Purchase 2,500 6.16 15,400
2008-03-05 Zabriskie John L (Director) Purchase 30,000 6.37 191,043
2008-02-26 Carruthers Michael (CFO) Option Exercise 22,165 .60 13,299
2008-02-12 Koch Kevin (President, CSO) Option Exercise 35,119 .24 8,252
2008-01-04 Carruthers Michael (CFO) Option Exercise 20,694 .24 4,863
2007-12-21 Conway Robert (CEO) Option Exercise 10,000 .60 6,000
2007-11-16 Conway Robert (CEO) Option Exercise 10,000 .60 6,000
2007-09-19 Carruthers Michael (CFO) Sale 10,000 13.00 130,000
2007-08-09 Van Lunsen Gil J (Director) Sale 12,000 11.47 137,662
2007-08-09 Van Lunsen Gil J (Director) Option Exercise 14,000 8.32 116,480
2007-02-15 Carruthers Michael (CFO) Option Exercise 20,000 .24 4,700
2007-02-05 Koch Kevin (President & CSO) Sale 20,000 14.06 281,100
2007-01-19 Koch Kevin (President & CSO) Sale 26,900 14.00 376,600
2006-12-27 Snitman David (COO and VP, Bus Development) Option Exercise 8,500 .24 1,997
2006-11-20 Moore John R (VP, General Counsel) Sale 27,263 13.04 355,509
2006-11-20 Moore John R (VP, General Counsel) Option Exercise 24,858 6.30 156,688
2006-11-15 Conway Robert (CEO) Sale 38,277 12.50 478,462
2006-11-15 Conway Robert (CEO) Option Exercise 63,277 .60 37,966
2006-11-14 Conway Robert (CEO) Sale 11,723 12.50 146,537
2006-11-14 Conway Robert (CEO) Option Exercise 11,723 .60 7,033
2006-11-13 Carruthers Michael (CFO) Sale 3,054 11.98 36,586
2006-11-10 Carruthers Michael (CFO) Sale 11,816 11.98 141,555
2006-11-09 Lefkoff Kyle (Director) Sale 51,000 11.80 601,800
2006-11-08 Carruthers Michael (CFO) Sale 10,000 10.85 108,500
2006-11-03 Conway Robert (CEO) Sale 83,755 10.01 838,387
2006-11-03 Conway Robert (CEO) Option Exercise 133,755 .60 80,253
2006-11-02 Conway Robert (CEO) Sale 16,245 10.00 162,450
2006-11-02 Conway Robert (CEO) Option Exercise 16,245 .60 9,747
2006-10-27 Carruthers Michael (CFO) Sale 5,000 9.95 49,750
2006-03-07 Carruthers Michael (CFO) Sale 5,000 9.49 47,450
2006-02-21 Lefkoff Kyle (Director) Sale 11,000 9.08 99,902
2006-02-17 Moore John R (VP, General Counsel) Sale 4,456 9.38 41,797
2006-02-17 Koch Kevin (President & CSO) Sale 20,000 9.38 187,680
2006-02-17 Carruthers Michael (CFO) Sale 5,000 8.99 44,950
2006-02-15 Carruthers Michael (CFO) Sale 5,000 8.49 42,450
2006-02-13 Carruthers Michael (CFO) Sale 4,403 8.15 35,895
2006-02-10 Carruthers Michael (CFO) Sale 4,506 8.16 36,768
2005-06-21 Carruthers Michael (CHIEF FINANCIAL OFFI) Sale 10,000 6.15 61,500
2005-03-24 Van Lunsen Gil J (Director) Purchase 1,315 7.47 9,823

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of ARRAY BIOPHARMA INC (symbol ARRY, CIK number 1100412) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.